← Eichor
Study identifier: NCT05767242 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Early Neurophysiological Markers of Language Impairments

Condition: Development, Infant · Development, Language · Developmental Language Disorder  ·  Sponsor: IRCCS Eugenio Medea

PhaseN/A
Planned participants100
Who can joinAll sexes, 6 Months to 8 Years
Healthy volunteersYes

About this study

The present project aims at identifying very early electrophysiological risk markers for language impairments. The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments. In this project, all the infants of the Medea BabyLab cohort are followed-up until school age. Since these infants have complete information on early electrophysiological markers, the final goal of the project is the characterization of their learning developmental trajectories and the construction of a multi-factor prognostic model that includes the neurophysiological processes underlying basic-level skills as potential biomarkers for predicting later reading and spelling skills.

This description comes directly from the study's public registry record.

Talk to the study team

Chiara Cantiani, PhD  ·  +39031877924  ·  chiara.cantiani@lanostrafamiglia.it

Always discuss trial participation with your own doctor first.

Locations (1)

Associazione La Nostra Famiglia - IRCCS Eugenio MedeaBosisio Parini, LC, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05767242